RecruitingNCT06387654

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Physiopathological Investigations of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases


Sponsor

University Hospital, Toulouse

Enrollment

800 participants

Start Date

May 6, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.


Eligibility

Min Age: 6 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Blood sampling and a biological treatment called Remainders of samples taken as part of the treatment for people with auto-inflammatory dermatological diseases, autoimmune bullous dermatosis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALBlood sampling

Blood will be taken in larger quantity

BIOLOGICALRemainders of samples taken as part of the treatment

blood, CSF, saliva, stools, urine, other biological fluids and tissue biopsies, hair follicles


Locations(1)

University Hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06387654


Related Trials